760 related articles for article (PubMed ID: 28355380)
1. Induced pluripotent stem cells reprogramming: Epigenetics and applications in the regenerative medicine.
Gomes KM; Costa IC; Santos JF; Dourado PM; Forni MF; Ferreira JC
Rev Assoc Med Bras (1992); 2017 Feb; 63(2):180-189. PubMed ID: 28355380
[TBL] [Abstract][Full Text] [Related]
2. The Epigenetic Reprogramming Roadmap in Generation of iPSCs from Somatic Cells.
Brix J; Zhou Y; Luo Y
J Genet Genomics; 2015 Dec; 42(12):661-70. PubMed ID: 26743984
[TBL] [Abstract][Full Text] [Related]
3. Current reprogramming systems in regenerative medicine: from somatic cells to induced pluripotent stem cells.
Hu C; Li L
Regen Med; 2016 Jan; 11(1):105-32. PubMed ID: 26679838
[TBL] [Abstract][Full Text] [Related]
4. DNA methylation dynamics in human induced pluripotent stem cells.
Nishino K; Umezawa A
Hum Cell; 2016 Jul; 29(3):97-100. PubMed ID: 27083573
[TBL] [Abstract][Full Text] [Related]
5. The miR-302-Mediated Induction of Pluripotent Stem Cells (iPSC): Multiple Synergistic Reprogramming Mechanisms.
Ying SY; Fang W; Lin SL
Methods Mol Biol; 2018; 1733():283-304. PubMed ID: 29435941
[TBL] [Abstract][Full Text] [Related]
6. Transcriptional and epigenetic mechanisms of cellular reprogramming to induced pluripotency.
van den Hurk M; Kenis G; Bardy C; van den Hove DL; Gage FH; Steinbusch HW; Rutten BP
Epigenomics; 2016 Aug; 8(8):1131-49. PubMed ID: 27419933
[TBL] [Abstract][Full Text] [Related]
7. Nuclear reprogramming and induced pluripotent stem cells: a review for surgeons.
Qi SD; Smith PD; Choong PF
ANZ J Surg; 2014 Jun; 84(6):417-23. PubMed ID: 24894037
[TBL] [Abstract][Full Text] [Related]
8. High-efficiency generation of induced pluripotent mesenchymal stem cells from human dermal fibroblasts using recombinant proteins.
Chen F; Zhang G; Yu L; Feng Y; Li X; Zhang Z; Wang Y; Sun D; Pradhan S
Stem Cell Res Ther; 2016 Jul; 7(1):99. PubMed ID: 27473118
[TBL] [Abstract][Full Text] [Related]
9. Integrated analysis of hematopoietic differentiation outcomes and molecular characterization reveals unbiased differentiation capacity and minor transcriptional memory in HPC/HSC-iPSCs.
Gao S; Hou X; Jiang Y; Xu Z; Cai T; Chen J; Chang G
Stem Cell Res Ther; 2017 Jan; 8(1):13. PubMed ID: 28114969
[TBL] [Abstract][Full Text] [Related]
10. Integration-free reprogramming of human somatic cells to induced pluripotent stem cells (iPSCs) without viral vectors, recombinant DNA, and genetic modification.
Heng BC; Fussenegger M
Methods Mol Biol; 2014; 1151():75-94. PubMed ID: 24838880
[TBL] [Abstract][Full Text] [Related]
11. Serum starvation-induced cell cycle synchronization stimulated mouse rDNA transcription reactivation during somatic cell reprogramming into iPSCs.
Zhao Q; Wu Y; Shan Z; Bai G; Wang Z; Hu J; Liu L; Li T; Shen J; Lei L
Stem Cell Res Ther; 2016 Aug; 7(1):112. PubMed ID: 27515169
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of Induction: Induced Pluripotent Stem Cells (iPSCs).
Singh VK; Kumar N; Kalsan M; Saini A; Chandra R
J Stem Cells; 2015; 10(1):43-62. PubMed ID: 26665937
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic regulation of somatic cell reprogramming.
Wang Y; Bi Y; Gao S
Curr Opin Genet Dev; 2017 Oct; 46():156-163. PubMed ID: 28823984
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic Aberrations Are Not Specific to Transcription Factor-Mediated Reprogramming.
Tiemann U; Wu G; Marthaler AG; Schöler HR; Tapia N
Stem Cell Reports; 2016 Jan; 6(1):35-43. PubMed ID: 26711876
[TBL] [Abstract][Full Text] [Related]
15. Role of epigenetics in cellular reprogramming; from iPSCs to disease modeling and cell therapy.
Li Y; Darabi R
J Cell Biochem; 2022 Feb; 123(2):147-154. PubMed ID: 34668236
[TBL] [Abstract][Full Text] [Related]
16. Genetic and Epigenetic Regulation of Human Cardiac Reprogramming and Differentiation in Regenerative Medicine.
Burridge PW; Sharma A; Wu JC
Annu Rev Genet; 2015; 49():461-84. PubMed ID: 26631515
[TBL] [Abstract][Full Text] [Related]
17. Redox and Epigenetics in Human Pluripotent Stem Cells Differentiation.
Giallongo S; Rehakova D; Raffaele M; Lo Re O; Koutna I; Vinciguerra M
Antioxid Redox Signal; 2021 Feb; 34(4):335-349. PubMed ID: 32567336
[No Abstract] [Full Text] [Related]
18. [Application of reprogramming technology for cancer research].
Yagi M; Semi K; Yamada Y
Nihon Rinsho; 2015 May; 73(5):751-5. PubMed ID: 25985626
[TBL] [Abstract][Full Text] [Related]
19. Hotspots of aberrant epigenomic reprogramming in human induced pluripotent stem cells.
Lister R; Pelizzola M; Kida YS; Hawkins RD; Nery JR; Hon G; Antosiewicz-Bourget J; O'Malley R; Castanon R; Klugman S; Downes M; Yu R; Stewart R; Ren B; Thomson JA; Evans RM; Ecker JR
Nature; 2011 Mar; 471(7336):68-73. PubMed ID: 21289626
[TBL] [Abstract][Full Text] [Related]
20. Cell type of origin influences iPSC generation and differentiation to cells of the hematoendothelial lineage.
Phetfong J; Supokawej A; Wattanapanitch M; Kheolamai P; U-Pratya Y; Issaragrisil S
Cell Tissue Res; 2016 Jul; 365(1):101-12. PubMed ID: 26893154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
